text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326197/2022

text: clinical

text: Baseline surveillance


status: PUBLIC

text: SARS-CoV-2: clinical or host-associated

tag: attribute

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: pda|emily.smith@theiagen.com

characteristic: INSDC center alias

text: pda|emily.smith@theiagen.com

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: CDPH VBL

text: USA: California

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326210/2022

characteristic: isolate

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: Baseline surveillance

characteristic: title


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326222/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326233/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326244/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326252/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326256/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326257/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326258/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326266/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326267/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326268/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326279/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326282/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326285/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326310/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326315/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326316/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326321/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326331/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326334/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326336/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326343/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326344/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326346/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326350/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326355/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326356/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326357/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326363/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326373/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326376/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326390/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326396/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326403/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326409/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326419/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326434/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326443/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326446/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326449/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326456/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326469/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326475/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326488/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326499/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326502/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326503/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326513/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326518/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326524/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326535/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326541/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326546/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326549/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326557/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326570/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326573/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326578/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326580/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326585/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326587/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326588/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326596/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326598/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326599/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326610/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326611/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326613/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326614/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326616/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326618/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326623/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326625/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326641/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326645/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326648/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326650/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326653/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326656/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326658/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326660/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326671/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326673/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326679/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326680/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326683/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326700/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326705/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326707/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326708/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326709/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326710/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326720/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326721/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326723/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326726/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326729/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326740/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326747/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326750/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326771/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326777/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326779/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326785/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326788/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326796/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326827/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326831/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326849/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326850/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326851/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326857/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326859/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326871/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326872/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326875/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326876/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326877/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326884/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326889/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326891/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326894/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326896/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326897/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326899/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326909/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326918/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326919/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326921/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326924/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326929/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326931/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326932/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326933/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326934/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326948/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326960/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326965/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326969/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326971/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326977/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326980/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326986/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326987/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326988/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326989/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326990/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326991/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326992/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326995/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326996/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000326997/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327001/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327002/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327004/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327008/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327013/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327014/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327016/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327018/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327019/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327024/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327026/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327030/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327034/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327039/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327045/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327057/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327062/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327073/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327081/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327086/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327108/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327109/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327111/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327119/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327120/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327134/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327141/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327143/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327154/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327160/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327164/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327165/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327166/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327173/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327174/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327177/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327182/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327186/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327188/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327189/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327192/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327195/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327206/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327208/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327209/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327212/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327221/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327227/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327228/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327229/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327232/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327233/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327234/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327245/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327246/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327247/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327252/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327257/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327260/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327268/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327273/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327274/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327276/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327279/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327282/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327288/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327293/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327294/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327297/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327302/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327304/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327307/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327309/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327310/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327312/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327406/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327418/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327419/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327437/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327444/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327452/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327471/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327506/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327509/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327513/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327514/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327517/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327522/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327523/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327524/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327536/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327544/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327557/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327563/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327569/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327570/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327571/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327575/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327584/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327586/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327588/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327589/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327592/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327593/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327595/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327598/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327601/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327607/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327618/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327621/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327645/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327646/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327655/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327657/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327660/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327661/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327664/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327676/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327677/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327682/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327692/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327700/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327702/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327704/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327705/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327707/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327710/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327714/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327720/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327725/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327727/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327731/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327732/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327735/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327739/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327740/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327759/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327771/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327777/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327871/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327892/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327893/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327895/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327896/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327898/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327913/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327925/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327928/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327932/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327939/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327940/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327954/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327958/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327959/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327960/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327962/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328336/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328339/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328347/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328348/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328351/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328357/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328375/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328410/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328413/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328426/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337046/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337055/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337056/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337074/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337076/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337082/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance